Guozhen Wu

机构：Wuhan University, Shanghai Public Health Clinical Center, Ministry of Education, Human Growth Foundation · ORCID：0009-0003-1994-7608

发表论文 17 篇 · 总被引 571 次 · h-index 13

代表论文

• Britanin Ameliorates Cerebral Ischemia–Reperfusion Injury by Inducing the Nrf2 Protective Pathway (2017 · Antioxidants and Redox Signaling · 被引 85)
• Stereoselective and site-divergent synthesis of C-glycosides (2024 · Nature Chemistry · 被引 69)
• Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis (2016 · Journal of Ethnopharmacology · 被引 56)
• Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from α-Santonin Derivatives (2017 · Journal of Medicinal Chemistry · 被引 54)
• Delavatine A, an unusual isoquinoline alkaloid exerts anti-inflammation on LPS-induced proinflammatory cytokines production by suppressing NF-κB activation in BV-2 microglia (2018 · Biochemical and Biophysical Research Communications · 被引 51)
• Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways (2017 · Cancer Letters · 被引 49)